Antimicrobial medical textiles market is slated to observe significant growth from 2021 to 2027 on account of increasing number of government initiatives and the rising technological advancements. The booming geriatric population and higher prevalence of chronic diseases has led to the mount in number of hospitalizations, further fueling the concerns over hospital-acquired infections. The ongoing developments in wound care, healthcare as well as the spiraling adoption of non-implantable goods will lead to market growth.
Antimicrobial medical textiles are primarily fiber substrates incorporated with antimicrobial agents to enhance the performance and lifespan of consumer products. The expanding medical tourism, improvements in healthcare practices, and hiking employment rate in the medical field are other factors fueling the market progression.
Antimicrobial medical textiles industry size from the cotton fabric is anticipated to collect substantial gains through 2027 owing to its vast use across medical, commercial, and home textiles. Considering its enhanced susceptibility to microbial attacks, the antimicrobial agents are applied to cotton textiles for suppressing the growth of microorganisms, as well as to limit odor generation and deterioration.
With regards to agents, the antimicrobial medical textiles market is bifurcated into metal & metallic salts, synthetic organic compounds, and bio-based agents. The synthetic organic compounds segment, comprising of quaternary ammonium compounds, polyhexamethylene biguanides (PHMB), and triclosan, will gain traction owing to increasing preference and affordability over its counterparts. The increasing use of quaternary ammonium compounds in a plethora of applications, like denaturation of proteins, and damages will add to the market expansion. However, the imposition of severe bans on use of triclosan and PHMB across certain parts of the world may restrict the product development to some extent.
The antimicrobial medical textiles industry share is expected to reach a considerable value from the healthcare & hygiene product applications. This is ascribing to the rising developments in the wound care market and the mounting awareness pertaining to hygiene, particularly in the emerging countries of Asia Pacific and Latin America.
North America is set to show notable proceeds for the antimicrobial medical textiles industry due to rising progressions in biotechnology and the upgrading of medical infrastructure. The swelling prevalence of various chronic disorders along with the limitations of drug therapies and treatment methods has led to the higher adoption of implantable goods. The mounting consumer awareness for proper health and hygiene as well as the ongoing commercialization of novel and improved products are other factors influencing the regional market growth.
Noble Biomaterials, Inc., Microban International (W.M. Barr & Company, Inc.), PurThread Technologies, Inc., Sciessent LLC, MediTEX Technology, DuPont Inc., Vestagen Protective Technologies, Inc., BioCote Limited, LifeThreads LLC, and Herculite are some of the major manufacturers of antimicrobial medical textiles across the globe.
Technological innovations for new product launches, along with strategic team-ups, including acquisitions and partnerships, as well as capacity expansions are the key measures employed by these companies to reinforce their market stronghold.
For instance, in March 2021, Mitsui & Co. Inc. renewed its distribution agreement with PurThread Technologies, Inc. to bring the latter’s patented permanent antimicrobial yarns and fibers to textiles as well as soft goods across its vast manufacturing and distribution networks in Japan.
Impact of the coronavirus crisis on antimicrobial medical textiles industry outlook
The COVID-19 pandemic made way for several hurdles in businesses as it substantially instigated the global economic landscape. On the flip side, the adoption of antimicrobial medical textiles reached a new height with extensive adoption to limit the antimicrobial activity as proved by several R&D activities. For instance, Sciessent applied the Agion antimicrobial agents to knit or woven medical textiles for its effectiveness against the virus.
The constant innovations led by numerous textile companies also added to the industry expansion. For instance, a Swiss textile innovation firm introduced an antiviral and antimicrobial textile treatment that inhibits the growth and the persistence of bacteria and viruses.